Your browser doesn't support javascript.
loading
Global scientific trends on exosomes therapy for osteoporosis from 2004 to 2023: A bibliometric and visualized analysis.
Lv, He; Feng, Zhe; Chen, Xingyu; Zhang, Zhenyu; Zhou, Tianhao; Wei, Jihu; Feng, Lin; Tao, Yizi; Chen, Feng; Lu, Shijin.
Afiliación
  • Lv H; Faculty of Postgraduate, Guangxi University of Chinese Medicine, Nanning, China.
  • Feng Z; Joint & Sports Medicine Surgery Division, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
  • Chen X; Faculty of Postgraduate, Guangxi University of Chinese Medicine, Nanning, China.
  • Zhang Z; Gynecology Department, Guangdong Medical University Shunde Women and Children's Hospital, Foshan, China.
  • Zhou T; Faculty of Postgraduate, Guangxi University of Chinese Medicine, Nanning, China.
  • Wei J; Faculty of Postgraduate, Guangxi University of Chinese Medicine, Nanning, China.
  • Feng L; Faculty of Postgraduate, Guangxi University of Chinese Medicine, Nanning, China.
  • Tao Y; Faculty of Postgraduate, Guangxi University of Chinese Medicine, Nanning, China.
  • Chen F; Spine Surgery Division, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
  • Lu S; Centre for Translational Medical Research in Integrative Chinese and Western Medicine, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
Medicine (Baltimore) ; 103(28): e38835, 2024 Jul 12.
Article en En | MEDLINE | ID: mdl-38996093
ABSTRACT

BACKGROUND:

Exosomes have emerged as pivotal mediators in modulating physiological and pathological processes implicated in osteoporosis (OP) through their distinctive mode of intracellular communication. The use of exosomes has evoked considerable interest, catalyzing a surge in research endeavors on a global scale. This study endeavors to scrutinize contemporary landscapes and burgeoning trends in this realm.

METHODS:

The Web of Science Core Collection was used to retrieve publications on exosomes therapy for OP within the time frame of January 1, 2004 to December 31, 2023. The bibliometric methodology was applied to study and index the collected data. VOSviewer and citespace software were used to conduct visualization, co-authorship, co-occurrence, and publication trend analyses of exosome therapy in OP.

RESULTS:

A total of 610 publications (443 articles and 167 reviews) from 51 countries and 911 institutions were included in this study. Shanghai Jiao Tong University, Central South University, Sichuan University, and Zhejiang University are leading research institutions in this field. Stem Cell Research Therapy published the highest number of articles and has emerged as the most cited journal. Of the 4077 scholars who participated in the study, Xie, Hui, Zhang, Yan, Tan, and Yi-Juan had the largest number of articles. Furthermore, according to the cluster analysis of external keywords, future research hotspots can be categorized into 3 directions research status of exosomes for the treatment of OP, treatment of OP through exosome-regulated signaling pathways, and exosomes as targeted drug delivery systems.

CONCLUSION:

This study suggests that the number of future publications on exosome therapy for OP will increase, with a focus on fundamental investigations into drug-loading capacities and molecular mechanisms. In summary, this study presents the first systematic bibliometric analysis of exosome therapy publications in OP, providing an objective and comprehensive overview of the field and a valuable reference for researchers in this domain.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Bibliometría / Exosomas Límite: Humans Idioma: En Revista: Medicine (Baltimore) Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Bibliometría / Exosomas Límite: Humans Idioma: En Revista: Medicine (Baltimore) Año: 2024 Tipo del documento: Article País de afiliación: China
...